Horizon Pharma (HZNP) Tops Q4 EPS by 7c, Offers FY Guidance

Horizon Pharma (NASDAQ: HZNP) reported Q4 EPS of $0.29, $0.07 better than the analyst estimate of $0.22. Revenue for the quarter came in at $274.2 million versus the consensus estimate of $264.48 million.

GUIDANCE:

Horizon Pharma sees FY2018 revenue of $1.15-1.18 billion, versus the consensus of $1.14 billion.

For earnings history and earnings-related data on Horizon Pharma (HZNP) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c